BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 23127227)

  • 1. Thiazolidinediones improve hepatic fibrosis in rats with non-alcoholic steatohepatitis by activating the adenosine monophosphate-activated protein kinase signalling pathway.
    Zhang W; Wu R; Zhang F; Xu Y; Liu B; Yang Y; Zhou H; Wang L; Wan K; Xiao X; Zhang X
    Clin Exp Pharmacol Physiol; 2012 Dec; 39(12):1026-33. PubMed ID: 23127227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone upregulates hepatic angiotensin converting enzyme 2 expression in rats with steatohepatitis.
    Zhang W; Li C; Liu B; Wu R; Zou N; Xu YZ; Yang YY; Zhang F; Zhou HM; Wan KQ; Xiao XQ; Zhang X
    Ann Hepatol; 2013; 12(6):892-900. PubMed ID: 24114819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
    Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
    Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice.
    Nan YM; Fu N; Wu WJ; Liang BL; Wang RQ; Zhao SX; Zhao JM; Yu J
    Scand J Gastroenterol; 2009; 44(3):358-65. PubMed ID: 18991162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osthole ameliorates insulin resistance by increment of adiponectin release in high-fat and high-sucrose-induced fatty liver rats.
    Qi Z; Xue J; Zhang Y; Wang H; Xie M
    Planta Med; 2011 Feb; 77(3):231-5. PubMed ID: 20717873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salsalate and adiponectin ameliorate hepatic steatosis by inhibition of the hepatokine fetuin-A.
    Jung TW; Youn BS; Choi HY; Lee SY; Hong HC; Yang SJ; Yoo HJ; Kim BH; Baik SH; Choi KM
    Biochem Pharmacol; 2013 Oct; 86(7):960-9. PubMed ID: 23948064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone ameliorates nonalcoholic steatohepatitis by down-regulating hepatic nuclear factor-kappa B and cyclooxygenases-2 expression in rats.
    Zhao JS; Zhu FS; Liu S; Yang CQ; Chen XM
    Chin Med J (Engl); 2012 Jul; 125(13):2316-21. PubMed ID: 22882855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperine reverses high fat diet-induced hepatic steatosis and insulin resistance in mice.
    Choi S; Choi Y; Choi Y; Kim S; Jang J; Park T
    Food Chem; 2013 Dec; 141(4):3627-35. PubMed ID: 23993530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adiponectin inhibits the activation of hepatic stellate cells induced by TGFb1 via up-regulating the expression of eNOS].
    Wang W; Zhao CY; Wang YD; He X; Shen C; Cao W; Zhou JY; Zhen Z
    Zhonghua Gan Zang Bing Za Zhi; 2011 Dec; 19(12):917-22. PubMed ID: 22525505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.
    Kawaguchi K; Sakaida I; Tsuchiya M; Omori K; Takami T; Okita K
    Biochem Biophys Res Commun; 2004 Feb; 315(1):187-95. PubMed ID: 15013444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiazolidinediones and the liver in humans.
    Yki-Järvinen H
    Curr Opin Lipidol; 2009 Dec; 20(6):477-83. PubMed ID: 19779336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone upregulates angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced nonalcoholic steatohepatitis.
    Zhang W; Xu YZ; Liu B; Wu R; Yang YY; Xiao XQ; Zhang X
    ScientificWorldJournal; 2014; 2014():603409. PubMed ID: 24558317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis.
    Wang W; Zhao C; Zhou J; Zhen Z; Wang Y; Shen C
    PLoS One; 2013; 8(10):e76538. PubMed ID: 24098525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
    Kitamura K; Tada S; Nakamoto N; Toda K; Horikawa H; Kurita S; Tsunematsu S; Kumagai N; Ishii H; Saito H; Hibi T
    J Gastroenterol Hepatol; 2007 Nov; 22(11):2022-33. PubMed ID: 17914985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease.
    Zaitone S; Hassan N; El-Orabi N; El-Awady el-S
    Eur J Pharmacol; 2011 Jul; 662(1-3):70-7. PubMed ID: 21549113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celecoxib attenuates liver steatosis and inflammation in non-alcoholic steatohepatitis induced by high-fat diet in rats.
    Chen J; Liu D; Bai Q; Song J; Guan J; Gao J; Liu B; Ma X; Du Y
    Mol Med Rep; 2011; 4(5):811-6. PubMed ID: 21643627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression.
    Abd El-Haleim EA; Bahgat AK; Saleh S
    Eur J Pharmacol; 2016 Feb; 773():59-70. PubMed ID: 26825546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ameliorating effect of rosiglitazone on experimental nonalcoholic steatohepatitis is associated with regulating adiponectin receptor expression in rats.
    Liu S; Wu HJ; Zhang ZQ; Chen Q; Liu B; Wu JP; Zhu L
    Eur J Pharmacol; 2011 Jan; 650(1):384-9. PubMed ID: 20965162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
    Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
    Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Simvastatin inhibits activation of hepatic stellate cells and promotes activation of adenosine monophosphate-activated protein kinase].
    Cao W; Yan L; Wang W; Zhao CY
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):304-9. PubMed ID: 22964154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.